Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer

Written Transcript at: Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American background. Along the way, they also talk about what is immunotherapy, how it works, how Provenge is actually administered, its side effects and who should get the treatment and where in their treatment schedule would it be best to get the treatment. Support the show

You can listen to Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

Understanding the Real Survival Advantages Provided By Provenge (Sipuleucel-T) for Men with Metastatic Prostate Cancer is an episode from Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer by Joel Nowak Cancer ABCs.

This episode is 42:19 long.

This episode was published on Sep 16, 2019.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer when more episodes are available from the podcast feed.